To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.

Bill: 118-hr-10050
Sponsor: full_name: Rep. Maloy, Celeste [R-UT-2]
Introduced: 2024-10-25
Policy area: Health
Latest action: action_date: 2024-12-17
text: Referred to the Subcommittee on Health.

Summaries:

tv_txt: I 118th CONGRESS 2d Session H. R. 10050 IN THE HOUSE OF REPRESENTATIVES October 25, 2024 Ms. Maloy (for herself, Mr. Krishnamoorthi , and Mrs. Harshbarger ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.

1. Study on pharmacy benefit manager audit practices Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall, taking into account input from independent pharmacists, pharmacy benefit managers, health care providers, and appropriate agencies, conduct a study and submit to Congress a report on audit practices of pharmacy benefit managers with respect to drugs dispensed under the Medicare and Medicaid programs, group health plans, and group or individual health insurance coverage. Such report shall include the following: (1) An assessment of the financial and operations impacts of current pharmacy benefit manager audit requirements on independent and other retail community pharmacies. (2) An evaluation of the appropriateness of current purchase documentation timeframes in relation to medication shelf lives, including with respect to medications that have a shelf life approved by the Food and Drug Administration of 2 years or more. (3) An evaluation of the transparency of current and historic pharmacy benefit manager audit requirements and recommendations on how to make such requirements more transparent and less burdensome on pharmacists. (4) Best practices for pharmacy benefit manager audit processes that ensure fairness and ease burdens on pharmacists without compromising the integrity of the audit.